Creative Biolabs has grouped a dedicated strong team who specializes in virology and understands the broad spectrum of coronavirus. Since the SARS outbreak in 2003 and the MERS outbreak in 2012, our professional virologists have been working to develop coronavirus vaccines and antiviral drugs. Over the years, we have accumulated expertise on coronavirus evolution, scientific methodology and continuously updated pathogenic mechanisms. At present, our coronavirus research team focuses on developing anti-inflammatory drugs, which is expected to be the next drug candidate for SARS-CoV-2. coronavirus release https://sars-cov-2.creative-biolabs.com/anti-inflammatory-drugs-for-the-treatment-of-sars-cov2.htm